by
Barbara Kram, Editor | December 26, 2006
Dietary Supplements and Nonprescription Drug Consumer Protection Act (S. 3546)
"The Dietary Supplements and Nonprescription Drug Consumer Protection Act is a step in the right direction toward stronger regulation of nonprescription drugs and dietary supplements. These drugs can cause serious side effects, and detrimental reactions when combined with prescription drugs. Currently, information about warnings, precautions, or side effects is rarely found on dietary supplement product labels, and manufacturers are not required to provide post marketing data to the FDA about adverse events. This bill will require adverse events reporting to the FDA, taking steps to help patients become better aware of the problems associated with dietary supplements and nonprescription drugs."
Sober Truth on Preventing Underage Drinking Act (STOP) (H.R. 864)
Ad Statistics
Times Displayed: 19090
Times Visited: 362 Stay up to date with the latest training to fix, troubleshoot, and maintain your critical care devices. GE HealthCare offers multiple training formats to empower teams and expand knowledge, saving you time and money
"The American Medical Association strongly supports action by Congress to pass the Sober Truth on Preventing Underage Drinking (STOP) Act, to help reduce the devastating consequences of underage drinking throughout the nation. The STOP Act will improve efforts to combat underage drinking by enhancing intergovernmental coordination, increasing research, and providing additional resources to local communities. The STOP Act is the first national underage drinking prevention legislation to be passed by Congress. The AMA is concerned about the health and social consequences of underage drinking. The STOP Act is a much-needed step in the right direction to help parents and communities reduce the devastating effects of underage drinking and save young lives."
Other recently passed, AMA-supported legislation include:
# H.R. 3248, Lifespan Respite Care Act, to develop and support respite care programs providing short-term, temporary care for patients with severe disabilities, chronic illnesses, or terminal illnesses
# S. 843, the Combating Autism Act of 2006, to combat autism through research, screening, intervention and education
# H.R. 5280, the Dextromethorphan Distribution Act of 2006, to prohibit the distribution of an unfinished active ingredient to any person other than a registered producer of drugs and devices in order to protect the public health
# H.R. 6344, to reauthorize the Office of National Drug Control Policy Act.
Back to HCB News
